Please provide your email address to receive an email when new articles are posted on . Timolol maleate 0.5% microdrops delivered with a volume-reducing adaptor provided noninferior IOP reduction ...
BERWYN, Pa.--(BUSINESS WIRE)--Amring Pharmaceuticals Inc. (Amring), a niche generic and brand pharmaceutical company, announced today that it has received FDA approval for generic Timolol Maleate ...
Compr Ophthalmol Update. 2005;6(2):85-101. In summary, the aqueous suppressors timolol gel once daily and brinzolamide are recommended first-line glaucoma agents often used together, with timolol gel ...
Glaukos has reported wins in a pair of late-phase clinical trials, teeing it up to seek FDA approval of its travoprost intraocular implant next year. The studies found the implant was noninferior to ...
Laser treatment has the potential to transform the management of glaucoma in Africa, and to prevent more people from going irreversibly blind, particularly in regions with high disease prevalence and ...
A South Florida drug maker recalled 199,584 bottles of three ophthalmic solutions because of a “lack of assurance on sterility.” That’s from FDA alert that the recalls from Apotex’s Weston facility ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback